Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-04

FDA Approved: CELEXA — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approves a supplemental application for CELEXA (citalopram) from Allergan, Inc., updating or expanding the product's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CELEXA (citalopram)

Snippet

SUPPL AP for CELEXA (CITALOPRAM)